Skip to main content
Erschienen in: The Cerebellum 1/2014

01.02.2014 | Original Paper

Clinical and Neurophysiological Profile of Four German Families with Spinocerebellar Ataxia Type 14

verfasst von: Christos Ganos, Simone Zittel, Martina Minnerop, Odette Schunke, Christina Heinbokel, Christian Gerloff, Christine Zühlke, Peter Bauer, Thomas Klockgether, Alexander Münchau, Tobias Bäumer

Erschienen in: The Cerebellum | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Spinocerebellar ataxia type 14 (SCA14) is an autosomal-dominant ataxia caused by point mutations of the Protein Kinase C Gamma gene. In addition to slowly progressive cerebellar ataxia, it is characterised by dystonia and myoclonus. With scant neuropathological data and no detailed neurophysiological examinations little is known on extracerebellar consequences of SCA14 related cerebellar pathology. To this end, we here delineate clinical phenomenology and neurophysiology of four German SCA14 families. Detailed clinical examination including ataxia severity evaluation by means of the Scale for the Assessment and Rating of Ataxia (SARA) was carried out in 9 affected family members (mean age 49.8 years ± 14.4 SD). Motor thresholds (MT), the contralateral silent period (CSP), short interval intracortical inhibition (SICI) and intracortical facilitation (ICF), interhemispheric inhibition (IHI) and short afferent inhibition (SAI) were determined using transcranial magnetic stimulation (TMS). Somatosensory evoked potentials (SEP) of the median nerve, and acoustic and visual evoked potentials (AEP, VEP) were also performed. Most patients reported symptoms since early childhood. There was a positive correlation between age and SARA scores (r = .721, P < 0.05). Patients had cerebellar ataxia, mild dystonia (focal, task-specific or segmental), subtle pyramidal signs and myoclonus. SICI increased with increasing conditioning pulse intensities in healthy controls but not in patients. Other neurophysiological parameters did not differ between groups. SCA14 is a slowly progressive ataxia associated with mild dystonia and myoclonus. Reduced SICI reflects abnormalities of intracortical inhibitory circuits.
Literatur
1.
Zurück zum Zitat Durr A. Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond. Lancet Neurol. 2010;9(9):885–94.PubMedCrossRef Durr A. Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond. Lancet Neurol. 2010;9(9):885–94.PubMedCrossRef
3.
Zurück zum Zitat van Gaalen J, Giunti P, van de Warrenburg BP. Movement disorders in spinocerebellar ataxias. Mov Disord. 2011;26:792–800.PubMedCrossRef van Gaalen J, Giunti P, van de Warrenburg BP. Movement disorders in spinocerebellar ataxias. Mov Disord. 2011;26:792–800.PubMedCrossRef
4.
Zurück zum Zitat Chen DH, Brkanac Z, Verlinde CL, et al. Missense mutations in the regulatory domain of PKC gamma: a new mechanism for dominant nonepisodic cerebellar ataxia. Am J Hum Genet. 2003;72:839–49.PubMedCentralPubMedCrossRef Chen DH, Brkanac Z, Verlinde CL, et al. Missense mutations in the regulatory domain of PKC gamma: a new mechanism for dominant nonepisodic cerebellar ataxia. Am J Hum Genet. 2003;72:839–49.PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Chen DH, Cimino PJ, Ranum LP, et al. The clinical and genetic spectrum of spinocerebellar ataxia 14. Neurology. 2005;64:1258–60.PubMedCrossRef Chen DH, Cimino PJ, Ranum LP, et al. The clinical and genetic spectrum of spinocerebellar ataxia 14. Neurology. 2005;64:1258–60.PubMedCrossRef
6.
Zurück zum Zitat Yamashita I, Sasaki H, Yabe I, et al. A novel locus for dominant cerebellar ataxia (SCA14) maps to a 10.2-cM interval flanked by D19S206 and D19S605 on chromosome 19q13.4-qter. Ann Neurol. 2000;48:156–63.PubMedCrossRef Yamashita I, Sasaki H, Yabe I, et al. A novel locus for dominant cerebellar ataxia (SCA14) maps to a 10.2-cM interval flanked by D19S206 and D19S605 on chromosome 19q13.4-qter. Ann Neurol. 2000;48:156–63.PubMedCrossRef
7.
Zurück zum Zitat Brkanac Z, Bylenok L, Fernandez M, et al. A new dominant spinocerebellar ataxia linked to chromosome 19q13.4-qter. Arch Neurol. 2002;59:1291–5.PubMedCrossRef Brkanac Z, Bylenok L, Fernandez M, et al. A new dominant spinocerebellar ataxia linked to chromosome 19q13.4-qter. Arch Neurol. 2002;59:1291–5.PubMedCrossRef
8.
Zurück zum Zitat Fahey MC, Knight MA, Shaw JH, et al. Spinocerebellar ataxia type 14: study of a family with an exon 5 mutation in the PRKCG gene. J Neurol Neurosurg Psychiatry. 2005;76:1720–2.PubMedCrossRef Fahey MC, Knight MA, Shaw JH, et al. Spinocerebellar ataxia type 14: study of a family with an exon 5 mutation in the PRKCG gene. J Neurol Neurosurg Psychiatry. 2005;76:1720–2.PubMedCrossRef
9.
Zurück zum Zitat Klebe S, Durr A, Rentschler A, et al. New mutations in protein kinase Cgamma associated with spinocerebellar ataxia type 14. Ann Neurol. 2005;58:720–9.PubMedCrossRef Klebe S, Durr A, Rentschler A, et al. New mutations in protein kinase Cgamma associated with spinocerebellar ataxia type 14. Ann Neurol. 2005;58:720–9.PubMedCrossRef
10.
Zurück zum Zitat van de Warrenburg BP, Verbeek DS, Piersma SJ, et al. Identification of a novel SCA14 mutation in a Dutch autosomal dominant cerebellar ataxia family. Neurology. 2003;61:1760–5.PubMedCrossRef van de Warrenburg BP, Verbeek DS, Piersma SJ, et al. Identification of a novel SCA14 mutation in a Dutch autosomal dominant cerebellar ataxia family. Neurology. 2003;61:1760–5.PubMedCrossRef
11.
Zurück zum Zitat Miura S, Nakagawara H, Kaida H, et al. Expansion of the phenotypic spectrum of SCA14 caused by the Gly128Asp mutation in PRKCG. Clin Neurol Neurosurg. 2009;111:211–5.PubMedCrossRef Miura S, Nakagawara H, Kaida H, et al. Expansion of the phenotypic spectrum of SCA14 caused by the Gly128Asp mutation in PRKCG. Clin Neurol Neurosurg. 2009;111:211–5.PubMedCrossRef
12.
Zurück zum Zitat Nolte D, Landendinger M, Schmitt E, Muller U. Spinocerebellar ataxia 14: novel mutation in exon 2 of PRKCG in a German family. Mov Disord. 2007;22:265–7.PubMedCrossRef Nolte D, Landendinger M, Schmitt E, Muller U. Spinocerebellar ataxia 14: novel mutation in exon 2 of PRKCG in a German family. Mov Disord. 2007;22:265–7.PubMedCrossRef
13.
Zurück zum Zitat Stevanin G, Hahn V, Lohmann E, et al. Mutation in the catalytic domain of protein kinase C gamma and extension of the phenotype associated with spinocerebellar ataxia type 14. Arch Neurol. 2004;61:1242–8.PubMedCrossRef Stevanin G, Hahn V, Lohmann E, et al. Mutation in the catalytic domain of protein kinase C gamma and extension of the phenotype associated with spinocerebellar ataxia type 14. Arch Neurol. 2004;61:1242–8.PubMedCrossRef
14.
Zurück zum Zitat Verbeek DS, Warrenburg BP, Hennekam FA, et al. Gly118Asp is a SCA14 founder mutation in the Dutch ataxia population. Hum Genet. 2005;117:88–91.PubMedCrossRef Verbeek DS, Warrenburg BP, Hennekam FA, et al. Gly118Asp is a SCA14 founder mutation in the Dutch ataxia population. Hum Genet. 2005;117:88–91.PubMedCrossRef
15.
Zurück zum Zitat Vlak MH, Sinke RJ, Rabelink GM, Kremer BP, van de Warrenburg BP. Novel PRKCG/SCA14 mutation in a Dutch spinocerebellar ataxia family: expanding the phenotype. Mov Disord. 2006;21:1025–8.PubMedCrossRef Vlak MH, Sinke RJ, Rabelink GM, Kremer BP, van de Warrenburg BP. Novel PRKCG/SCA14 mutation in a Dutch spinocerebellar ataxia family: expanding the phenotype. Mov Disord. 2006;21:1025–8.PubMedCrossRef
16.
Zurück zum Zitat Foncke EM, Beukers RJ, Tijssen CC, Koelman JH, Tijssen MA. Myoclonus-dystonia and spinocerebellar ataxia type 14 presenting with similar phenotypes: trunk tremor, myoclonus, and dystonia. Parkinsonism Relat Disord. 2010;16:288–9.PubMedCrossRef Foncke EM, Beukers RJ, Tijssen CC, Koelman JH, Tijssen MA. Myoclonus-dystonia and spinocerebellar ataxia type 14 presenting with similar phenotypes: trunk tremor, myoclonus, and dystonia. Parkinsonism Relat Disord. 2010;16:288–9.PubMedCrossRef
17.
Zurück zum Zitat Visser JE, Bloem BR, van de Warrenburg BP. PRKCG mutation (SCA-14) causing a Ramsay Hunt phenotype. Mov Disord. 2007;22:1024–6.PubMedCrossRef Visser JE, Bloem BR, van de Warrenburg BP. PRKCG mutation (SCA-14) causing a Ramsay Hunt phenotype. Mov Disord. 2007;22:1024–6.PubMedCrossRef
18.
Zurück zum Zitat Saito N, Kikkawa U, Nishizuka Y, Tanaka C. Distribution of protein kinase C-like immunoreactive neurons in rat brain. J Neurosci. 1988;8:369–82.PubMed Saito N, Kikkawa U, Nishizuka Y, Tanaka C. Distribution of protein kinase C-like immunoreactive neurons in rat brain. J Neurosci. 1988;8:369–82.PubMed
19.
Zurück zum Zitat Liepert J, Wessel K, Schwenkreis P, et al. Reduced intracortical facilitation in patients with cerebellar degeneration. Acta Neurol Scand. 1998;98:318–23.PubMedCrossRef Liepert J, Wessel K, Schwenkreis P, et al. Reduced intracortical facilitation in patients with cerebellar degeneration. Acta Neurol Scand. 1998;98:318–23.PubMedCrossRef
20.
Zurück zum Zitat Restivo DA, Lanza S, Saponara R, Rapisarda G, Giuffrida S, Palmeri A. Changes of cortical excitability of human motor cortex in spinocerebellar ataxia type 2. A study with paired transcranial magnetic stimulation. J Neurol Sci. 2002;198(1–2):87–92.PubMedCrossRef Restivo DA, Lanza S, Saponara R, Rapisarda G, Giuffrida S, Palmeri A. Changes of cortical excitability of human motor cortex in spinocerebellar ataxia type 2. A study with paired transcranial magnetic stimulation. J Neurol Sci. 2002;198(1–2):87–92.PubMedCrossRef
21.
Zurück zum Zitat Schwenkreis P, Tegenthoff M, Witscher K, et al. Motor cortex activation by transcranial magnetic stimulation in ataxia patients depends on the genetic defect. Brain. 2002;125:301–9.PubMedCrossRef Schwenkreis P, Tegenthoff M, Witscher K, et al. Motor cortex activation by transcranial magnetic stimulation in ataxia patients depends on the genetic defect. Brain. 2002;125:301–9.PubMedCrossRef
22.
Zurück zum Zitat Wessel K, Tegenthoff M, Vorgerd M, Otto V, Nitschke MF, Malin JP. Enhancement of inhibitory mechanisms in the motor cortex of patients with cerebellar degeneration: a study with transcranial magnetic brain stimulation. Electroencephalogr Clin Neurophysiol. 1996;101:273–80.PubMedCrossRef Wessel K, Tegenthoff M, Vorgerd M, Otto V, Nitschke MF, Malin JP. Enhancement of inhibitory mechanisms in the motor cortex of patients with cerebellar degeneration: a study with transcranial magnetic brain stimulation. Electroencephalogr Clin Neurophysiol. 1996;101:273–80.PubMedCrossRef
23.
Zurück zum Zitat Oechsner M, Zangemeister WH. Prolonged postexcitatory inhibition after transcranial magnetic stimulation of the motor cortex in patients with cerebellar ataxia. J Neurol Sci. 1999;168:107–11.PubMedCrossRef Oechsner M, Zangemeister WH. Prolonged postexcitatory inhibition after transcranial magnetic stimulation of the motor cortex in patients with cerebellar ataxia. J Neurol Sci. 1999;168:107–11.PubMedCrossRef
24.
Zurück zum Zitat Restivo DA, Lanza S, Giuffrida S, et al. Cortical silent period prolongation in spinocerebellar ataxia type 2 (SCA2). Funct Neurol. 2004;19:37–41.PubMed Restivo DA, Lanza S, Giuffrida S, et al. Cortical silent period prolongation in spinocerebellar ataxia type 2 (SCA2). Funct Neurol. 2004;19:37–41.PubMed
25.
Zurück zum Zitat Teo JT, Schneider SA, Cheeran BJ, et al. Prolonged cortical silent period but normal sensorimotor plasticity in spinocerebellar ataxia 6. Mov Disord. 2008;23:378–85.PubMedCrossRef Teo JT, Schneider SA, Cheeran BJ, et al. Prolonged cortical silent period but normal sensorimotor plasticity in spinocerebellar ataxia 6. Mov Disord. 2008;23:378–85.PubMedCrossRef
26.
Zurück zum Zitat Berardelli A, Abbruzzese G, Chen R, et al. Consensus paper on short-interval intracortical inhibition and other transcranial magnetic stimulation intracortical paradigms in movement disorders. Brain Stimul. 2008;1:183–91.PubMedCrossRef Berardelli A, Abbruzzese G, Chen R, et al. Consensus paper on short-interval intracortical inhibition and other transcranial magnetic stimulation intracortical paradigms in movement disorders. Brain Stimul. 2008;1:183–91.PubMedCrossRef
27.
Zurück zum Zitat Cakmur R, Donmez B, Uzunel F, Aydin H, Kesken S. Evidence of widespread impairment of motor cortical inhibition in focal dystonia: a transcranial magnetic stimulation study in patients with blepharospasm and cervical dystonia. Adv Neurol. 2004;94:37–44.PubMed Cakmur R, Donmez B, Uzunel F, Aydin H, Kesken S. Evidence of widespread impairment of motor cortical inhibition in focal dystonia: a transcranial magnetic stimulation study in patients with blepharospasm and cervical dystonia. Adv Neurol. 2004;94:37–44.PubMed
28.
Zurück zum Zitat Curra A, Berardelli A, Rona S, Fabri S, Manfredi M. Excitability of motor cortex in patients with dystonia. Adv Neurol. 1998;78:33–40.PubMed Curra A, Berardelli A, Rona S, Fabri S, Manfredi M. Excitability of motor cortex in patients with dystonia. Adv Neurol. 1998;78:33–40.PubMed
29.
Zurück zum Zitat Edwards MJ, Huang YZ, Wood NW, Rothwell JC, Bhatia KP. Different patterns of electrophysiological deficits in manifesting and non-manifesting carriers of the DYT1 gene mutation. Brain. 2003;126:2074–80.PubMedCrossRef Edwards MJ, Huang YZ, Wood NW, Rothwell JC, Bhatia KP. Different patterns of electrophysiological deficits in manifesting and non-manifesting carriers of the DYT1 gene mutation. Brain. 2003;126:2074–80.PubMedCrossRef
30.
Zurück zum Zitat Ridding MC, Sheean G, Rothwell JC, Inzelberg R, Kujirai T. Changes in the balance between motor cortical excitation and inhibition in focal, task specific dystonia. J Neurol Neurosurg Psychiatry. 1995;59:493–8.PubMedCrossRef Ridding MC, Sheean G, Rothwell JC, Inzelberg R, Kujirai T. Changes in the balance between motor cortical excitation and inhibition in focal, task specific dystonia. J Neurol Neurosurg Psychiatry. 1995;59:493–8.PubMedCrossRef
31.
Zurück zum Zitat Roze E, Apartis E, Trocello JM. Cortical excitability in DYT-11 positive myoclonus dystonia. Mov Disord. 2008;23:761–4.PubMedCrossRef Roze E, Apartis E, Trocello JM. Cortical excitability in DYT-11 positive myoclonus dystonia. Mov Disord. 2008;23:761–4.PubMedCrossRef
32.
Zurück zum Zitat van der Salm SM, van Rootselaar AF, Foncke EM, et al. Normal cortical excitability in Myoclonus-Dystonia–a TMS study. Exp Neurol. 2009;216:300–5.PubMedCrossRef van der Salm SM, van Rootselaar AF, Foncke EM, et al. Normal cortical excitability in Myoclonus-Dystonia–a TMS study. Exp Neurol. 2009;216:300–5.PubMedCrossRef
33.
Zurück zum Zitat Hanajima R, Okabe S, Terao Y, et al. Difference in intracortical inhibition of the motor cortex between cortical myoclonus and focal hand dystonia. Clin Neurophysiol. 2008;119:1400–7.PubMedCrossRef Hanajima R, Okabe S, Terao Y, et al. Difference in intracortical inhibition of the motor cortex between cortical myoclonus and focal hand dystonia. Clin Neurophysiol. 2008;119:1400–7.PubMedCrossRef
34.
Zurück zum Zitat Brown P, Ridding MC, Werhah KJ, Rothwell JC, Marsden CD. Abnormalities of the balance between inhibition and excitation in the motor cortex of patients with cortical myoclonus. Brain. 1996;119:309–17.PubMedCrossRef Brown P, Ridding MC, Werhah KJ, Rothwell JC, Marsden CD. Abnormalities of the balance between inhibition and excitation in the motor cortex of patients with cortical myoclonus. Brain. 1996;119:309–17.PubMedCrossRef
35.
Zurück zum Zitat Schmitz-Hubsch T, du Montcel ST, Baliko L, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66:1717–20.PubMedCrossRef Schmitz-Hubsch T, du Montcel ST, Baliko L, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66:1717–20.PubMedCrossRef
36.
Zurück zum Zitat Kujirai T, Caramia MD, Rothwell JC, et al. Corticocortical inhibition in human motor cortex. J Physiol. 1993;471:501–19.PubMed Kujirai T, Caramia MD, Rothwell JC, et al. Corticocortical inhibition in human motor cortex. J Physiol. 1993;471:501–19.PubMed
37.
Zurück zum Zitat Tamburin S, Fiaschi A, Marani S, Andreoli A, Manganotti P, Zanette G. Enhanced intracortical inhibition in cerebellar patients. J Neurol Sci. 2004;217:205–10.PubMedCrossRef Tamburin S, Fiaschi A, Marani S, Andreoli A, Manganotti P, Zanette G. Enhanced intracortical inhibition in cerebellar patients. J Neurol Sci. 2004;217:205–10.PubMedCrossRef
38.
Zurück zum Zitat Yokota T, Sasaki H, Iwabuchi K, et al. Electrophysiological features of central motor conduction in spinocerebellar atrophy type 1, type 2, and Machado-Joseph disease. J Neurol Neurosurg Psychiatry. 1998;65:530–4.PubMedCrossRef Yokota T, Sasaki H, Iwabuchi K, et al. Electrophysiological features of central motor conduction in spinocerebellar atrophy type 1, type 2, and Machado-Joseph disease. J Neurol Neurosurg Psychiatry. 1998;65:530–4.PubMedCrossRef
39.
Zurück zum Zitat Ziemann U, Lonnecker S, Steinhoff BJ, Paulus W. Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann Neurol. 1996;40:367–78.PubMedCrossRef Ziemann U, Lonnecker S, Steinhoff BJ, Paulus W. Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann Neurol. 1996;40:367–78.PubMedCrossRef
40.
Zurück zum Zitat Ugawa Y, Hanajima R, Kanazawa I. Motor cortex inhibition in patients with ataxia. Electroencephalogr Clin Neurophysiol. 1994;93:225–9.PubMedCrossRef Ugawa Y, Hanajima R, Kanazawa I. Motor cortex inhibition in patients with ataxia. Electroencephalogr Clin Neurophysiol. 1994;93:225–9.PubMedCrossRef
41.
Zurück zum Zitat Defazio G, Berardelli A, Hallett M. Do primary adult-onset focal dystonias share aetiological factors? Brain. 2007;130(Pt 5):1183–93.PubMedCrossRef Defazio G, Berardelli A, Hallett M. Do primary adult-onset focal dystonias share aetiological factors? Brain. 2007;130(Pt 5):1183–93.PubMedCrossRef
42.
Zurück zum Zitat Ridding MC, Inzelberg R, Rothwell JC. Changes in excitability of motor cortical circuitry in patients with Parkinson's disease. Ann Neurol. 1995;37:181–8.PubMedCrossRef Ridding MC, Inzelberg R, Rothwell JC. Changes in excitability of motor cortical circuitry in patients with Parkinson's disease. Ann Neurol. 1995;37:181–8.PubMedCrossRef
43.
Zurück zum Zitat Gilio F, Curra A, Lorenzano C, Modugno N, Manfredi M, Berardelli A. Effects of botulinum toxin type A on intracortical inhibition in patients with dystonia. Ann Neurol. 2000;48:20–6.PubMedCrossRef Gilio F, Curra A, Lorenzano C, Modugno N, Manfredi M, Berardelli A. Effects of botulinum toxin type A on intracortical inhibition in patients with dystonia. Ann Neurol. 2000;48:20–6.PubMedCrossRef
44.
45.
Zurück zum Zitat Vucic S, Nicholson GA, Kiernan MC. Cortical excitability in hereditary motor neuronopathy with pyramidal signs: comparison with ALS. J Neurol Neurosurg Psychiatry. 2010;81:97–100.PubMedCrossRef Vucic S, Nicholson GA, Kiernan MC. Cortical excitability in hereditary motor neuronopathy with pyramidal signs: comparison with ALS. J Neurol Neurosurg Psychiatry. 2010;81:97–100.PubMedCrossRef
Metadaten
Titel
Clinical and Neurophysiological Profile of Four German Families with Spinocerebellar Ataxia Type 14
verfasst von
Christos Ganos
Simone Zittel
Martina Minnerop
Odette Schunke
Christina Heinbokel
Christian Gerloff
Christine Zühlke
Peter Bauer
Thomas Klockgether
Alexander Münchau
Tobias Bäumer
Publikationsdatum
01.02.2014
Verlag
Springer US
Erschienen in
The Cerebellum / Ausgabe 1/2014
Print ISSN: 1473-4222
Elektronische ISSN: 1473-4230
DOI
https://doi.org/10.1007/s12311-013-0522-7

Weitere Artikel der Ausgabe 1/2014

The Cerebellum 1/2014 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.